Article

Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of nsp5 Main Protease

2021-04-08

Abstract excerpt

<h4>Summary</h4> The coronavirus 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread around the world with unprecedented health and socio-economic effects for the global population. While different vaccines are now being made available, very few antiviral drugs have been approved. The main viral protease (nsp5) of SARS-CoV-2 provides an excellent target for...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fbd158aa-9a5d-520b-8bc5-153cb6f11740
DOI: 10.1101/2021.04.07.438806

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of nsp5 Main ProteaseDOI 10.1101/2021.04.07.438806Read

Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp3 Papain-like ProteaseSemantic proximity Read

Novel inhibitors against COVID-19 main protease suppressed viral infectionSemantic proximity Read

Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp13 HelicaseSemantic proximity Read

Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19Semantic proximity Read

An oral non-covalent non-peptidic inhibitor of SARS-CoV-2 Mpro ameliorates viral replication and pathogenesis in vivoSemantic proximity Read

Structural basis for the inhibition of coronaviral main proteases by PF-00835231.Semantic proximity Read

Structural basis for the inhibition of coronaviral main proteases by PF-00835231Semantic proximity Read

Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistanceSemantic proximity Read

Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitorsSemantic proximity Read

Challenges for targeting SARS-CoV-2 proteases as a therapeutic strategy for COVID-19Semantic proximity Read

Structure-based design of pan-coronavirus inhibitors targeting host cathepsin L and calpain-1Semantic proximity Read

High Throughput Virtual Screening and Validation of a SARS-CoV-2 Main Protease Non-Covalent InhibitorSemantic proximity Read